NCT04145271

Brief Summary

It is unknown whether this evolved strategy (Pre-Hospital Zone I P-REBOA) is feasible and with an acceptable safety profile. This study will address this question, therefore informing the design of a prospective multicentre exploratory cohort study followed by a pilot/feasibility multicenter RCT (IDEAL 2B). The IDEAL Framework is an internationally recognised standard, that describes the stages through which interventional therapy innovation normally passes, the characteristics of each stage and the study design types recommended for each

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 30, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

June 27, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

May 9, 2022

Status Verified

May 1, 2022

Enrollment Period

1.8 years

First QC Date

September 4, 2019

Last Update Submit

May 6, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Zone 1 REBOA

    The proportion of patients where Pre-Hospital Zone 1 REBOA is achieved, defined as: * Balloon insertion depth between 35 - 55 cm * Proximal arterial blood pressure transduced * Balloon inflation

    1 day

  • Partial REBOA (P-REBOA)

    The proportion of Pre-Hospital Zone 1 REBOA patients where P-REBOA is achieved, defined as: * Evidence of an increase in distal mean arterial pressure (MAP) of at least 5mm - 10mmHg above post inflation baseline; * and/or a return of distal pulsatility; * or distal pulsatility never absent post initial balloon inflation.

    1 day

Secondary Outcomes (16)

  • • Incidence of Zone I balloon positioning in the ED

    1 Days

  • • Incidence of pre-hospital balloon migration

    1 Day

  • • Incidence of balloon repositioning (proximal or distal) pre or in-hospital.

    1 Day

  • • Method of achieving Partial REBOA

    1 Day

  • • Incidence of failed femoral arterial access

    1 Day

  • +11 more secondary outcomes

Interventions

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a minimally invasive damage control procedure for life-threatening abdominal and/or pelvic haemorrhage. It involves temporary occlusion of the aorta with an endovascular balloon, providing proximal control to the site of vascular injury whilst supporting cerebral and myocardial perfusion

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

8 Patients cannulated for REBOA (+ all other patients meeting the inclusion criteria during the study period where there was a failed attempt at femoral arterial access).

You may qualify if:

  • Adult trauma patients (aged, or believed to be aged 16 years or older) attended by LAA;
  • assessed to have exsanguinating sub-diaphragmatic haemorrhage and imminent risk of hypovolaemic cardiac arrest, or recent hypovolaemic cardiac arrest;
  • which is thought to be amenable to treatment with Zone I REBOA;
  • and an attempt is made at femoral arterial access (percutaneous access or open surgical approach to insert 8Fr REBOA access sheath)

You may not qualify if:

  • Age \< 16 years
  • Injuries deemed clinically unsurvivable
  • Known or visible advanced pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Royal London Hospital

London, E1 1FR, United Kingdom

Location

London HEMS

London, E1, United Kingdom

Location

St. Georges Hospital

London, SW17 0QT, United Kingdom

Location

St.Marys Hospital

London, W2 1NY, United Kingdom

Location

Related Publications (2)

  • Lendrum RA, Perkins Z, Marsden M, Cochran C, Davenport R, Chege F, Fitzpatrick-Swallow V, Greenhalgh R, Wohlgemut JM, Henry CL, Singer B, Grier G, Davies G, Bunker N, Nevin D, Christian M, Campbell MK, Tai N, Johnson A, Jansen JO, Sadek S, Brohi K. Prehospital Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Exsanguinating Subdiaphragmatic Hemorrhage. JAMA Surg. 2024 Sep 1;159(9):998-1007. doi: 10.1001/jamasurg.2024.2254.

  • Lawrie L, Duncan EM, Lendrum R, Lebrec V, Gillies K. Challenges and opportunities for conducting pre-hospital trauma trials: a behavioural investigation. Trials. 2023 Mar 2;24(1):157. doi: 10.1186/s13063-023-07184-5.

MeSH Terms

Conditions

EmergenciesAccidental InjuriesMultiple Trauma

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsWounds and Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2019

First Posted

October 30, 2019

Study Start

June 27, 2020

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

May 9, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations